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Emergency stent graft implantation for ruptured
visceral artery pseudoaneurysm
Mourad Boufi, MD,a Hicham Belmir, MD,a Olivier Hartung, MD,a Olivier Ramis, MD,b
Laura Beyer, MD,c and Yves S. Alimi, PhD,a Marseille, France
Background: Literature series that include visceral artery pseudoaneurysms rarely separate them from true aneurysms,
although they address different issues. Guidelines for optimal management of these lesions are lacking. We report our
experience of stent graft treatment of these lesions with midterm results.
Methods:We retrospectively reviewed all patients with a visceral pseudoaneurysmwhowere treated with a stent graft in our
institution. Patient history, clinical characteristics, procedure details, and outcome were recorded and analyzed.
Results: FromMarch 2004 to June 2009, 10 consecutive patients (9 men), who were a mean age of 59 years, were treated
for symptomatic visceral artery pseudoaneurysm, with hemorrhagic shock in 8 patients (80%), after pancreaticoduode-
nectomy in 8, gastrectomy in 1, and abdominal trauma in 1. A mean of 24 days (range, 7-60 days) passed between the
initial surgery or trauma and pseudoaneurysm diagnosis. Septic complications were associated in six patients (60%). The
pseudoaneurysm was in the hepatic artery in 8 patients, the splenic artery in 1, and the superior mesenteric artery in 1.
Technical and clinical success was achieved in 80% of patients. Two failures of catheterization were followed by redo
surgery and death (20%). No patients died postoperatively, and no complications among the patients who were treated
successfully. Mean follow-up was 37 months (range, 10-63 months). All stent grafts were patent, with no signs of
infection. Two patients died secondary to neoplasm. No rebleeding or recurrent aneurysms were noted.
Conclusion: Stent graft exclusion of visceral artery pseudoaneurysm seems to be a valid therapeutic approach regardless of
the patient’s septic or hemodynamic status. ( J Vasc Surg 2011;53:1625-31.)
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tVisceral artery pseudoaneurysm is a rare1 and severe
complication in abdominal surgery, trauma, infection, or
inflammatory disease, as well as in percutaneous or endo-
scopic explorations of the biliary tract. Rupture remains an
unpredictable and lethal complication of this pathology.2
Management of visceral artery pseudoaneurysm can be
surgical or endovascular. Surgical treatment, including re-
vascularization, artery ligation, or end-organ resection, is
associated with high mortality rates of 5% to 25%.3-6 Em-
bolization is a safe and less invasive technique than open
surgery,7 but it carries a significant failure rate and excludes
distal circulation, which can compromise organ func-
tion.8-12
Reports have emerged describing stent graft exclusion
of pseudoaneurysm as an alternative that compensates for
the disadvantages of embolization.13-16 These reports con-
cern individual cases or small series with only short-term
results.17 The present article describes our experience with
stent graft deployment in the treatment of ruptured visceral
artery pseudoaneurysms after operations or trauma and
analyzes the midterm results.
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doi:10.1016/j.jvs.2011.02.003ATERIAL AND METHODS
From March 2004 to June 2009, we retrospectively
eviewed all patients who had undergone endovascular
reatment of visceral pseudoaneurysms with a stent graft.
he diagnosis of pseudoaneurysm was determined by clin-
cal context and imaging criteria. The first-intention treat-
ent of all the pseudoaneurysms diagnosed, including
hose that were asymptomatic, was endovascular, and sur-
ical repair was initiated if the endovascular approach failed.
The clinical characteristics of the patients were re-
orded, including age, sex, initial pathology, time of onset,
ymptoms at presentation, hemodynamic and septic status,
reoperative imaging, and technical and clinical outcomes.
ll patients had preoperative computed tomography (CT)
maging, making it possible to diagnose the pseudoaneu-
ysm with or without active bleeding.
Severe hemorrhage was defined as one dof (1) 200
L of blood lost through a surgical drain or gastrointesti-
al tract, (2) a drop in hemoglobin concentration of 3
/dL, or (3) the need for 2 units of a packed red blood
ell transfusion during a 24-hour period.18 Sentinel bleed-
ng was defined as a small amount of blood loss through
eritoneal drains or a nasogastric tube several hours before
assive hemorrhage.19
Stent graft placements were proposed as the first inten-
ion when the anatomic conditions were satisfied or when
mbolization was contraindicated because of the risk of
ompromising organ perfusion, notably in case of hepatic
rtery pseudoaneurysm with portal vein thrombosis. Stent
rafts were also deployed, as the second intention, after
echnical failure of embolization or recurrent bleeding sec-
ndary to embolization.
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ally occurred in the operating theater with the patient
placed under general anesthesia. Procedures in patients
with hemodynamic stability occurred in the angiographic
suite with local anesthesia and conscious sedation. The
procedures were performed using a femoral or brachial
access.
After global abdominal aortography, the affected artery
was selectively catheterized using a 5F Cobra catheter to
check the accessibility of the lesion to stent grafting. An
8F-long sheath (Flexor, Cook, Cook Inc, Bloomington,
Ind) was then advanced over a stiff, 0.035-inch 18-cm
Amplatz guidewire (Boston Scientific Corp, Natick, Mass)
and engaged in the ostia of the visceral vessel. Because of
the fragility of the artery and the risk of rupture, we tried to
avoid positioning the sheath too close to the pseudoaneu-
rysm. After stent graft deployment, an angiogram was
performed to assess the exclusion of the pseudoaneurysm
and the patency of the treated artery and its branches.
All patients had antibiotic prophylaxis during the pro-
cedure. After the procedure, no heparin or antiplatelet
medication was given to hemodynamically unstable pa-
tients with coagulation disorders. The other patients re-
ceived aspirin (160 mg/day) and clopidogrel (75 mg/day)
for 3 to 6 months. Antibiotic therapy in patients with
preoperative sepsis was continued for 3 to 6 months.
Immediate technical success was defined as the success-
ful deployment of the stent graft and the exclusion of the
pseudoaneurysm with no endoleak. Clinical success was
defined as improved hemodynamic status within a few
hours of the procedures or resolution of the symptoms
related to the pseudoaneurysm, or both.
After discharge, the follow-up protocol depended on
the initial pathology. For malignant lesions, a clinical exam-
ination and CT scan were done every 4 months for the first
2 years and then every 6 months for the next 3 years. The
follow-up protocol for benign lesions included a clinical
examination and Doppler ultrasound imaging every 6
months and a CT scan yearly for 2 years. The patient with a
post-trauma pseudoaneurysm had a clinical examination
and CT imaging at 1, 6, and 12 months. All potentially
adverse events in relation to the endovascular procedure
and deaths were recorded during the follow-up.
RESULTS
We encountered 15 visceral artery pseudoaneurysms in
the 1620 trauma and 8700 general surgical admissions with
127 pancreaticoduodenectomy procedures performed dur-
ing the 5-year period. Of these, the treatment intention for
nine patients was to use a stent graft and embolization with
the other six. Three of the patients in the embolization
group were not good candidates for stent grafting because
of unfavorable anatomy. The remaining three patients were
suitable for both techniques, but the physician chose arte-
rial embolization. One of these patients presented with
recurrent bleeding and was then treated with a stent graft
(Fig 1). nOverall, our study population consisted of 10 patients
9 men) who were a mean age of 59 years (range, 23-75
ears). Pseudoaneurysms were caused by cancer surgery in
ig 1. A, A selective angiogram of the celiac artery shows the
seudoaneurysm of the gastroduodenal artery stump with contrast
xtravasation into the bowel. B, Coil embolization of the gas-
roduodenal artery stump shows no evidence of contrast extrava-
ation. C, The gastroduodenal artery was completely excluded
sing a stent graft. The patient presented 1 week later for recur-
ence of gastrointestinal bleeding.ine patients and blunt abdominal trauma 8 weeks earlier in
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Volume 53, Number 6 Boufi et al 1627one patient. Indications for the initial surgery were head
pancreatic carcinoma in 3, common bile duct carcinoma in
2, gastrointestinal tract cancer in 2, mucinous neoplasm in
1, and endocrine tumor in 1. The surgical procedures were
pylorus-preserving pancreaticoduodenectomy with an end-
to-side pancreaticogastrostomy in eight patients and sub-
total gastrectomy with colectomy in one. A retroperitoneal
lymphadenectomy was performed in all seven cases.
Symptoms at presentation included externalized bleed-
ing through the gastrointestinal tract (upper gastrointesti-
nal bleeding or melenic stools) in nine patients or through
abdominal drains in two, or both. Sentinel bleeding was
noted in three patients 1 to 7 days before diagnosis.
Eight patients (80%) were hemodynamically unstable
at the time of endovascular management. Signs of sepsis
were found in 6 patients (60%) revealed by a combination
of bacteremia in 5, abdominal collection on CT scan in 4,
and digestive anastomotic leakage in 2. CT imaging sug-
gesting sepsis includes a retained loculated fluid collection,
with rim enhancement around the pancreatic bed and the
enteric anastomosis. The presence of air bubbles in the fluid
at these sites is also strongly suggestive of infection. Pan-
creatic fistulas were confirmed with laboratory analysis in
two patients. Different microorganisms were identified in
culture (Table), in particular, gram-negative bacterium.
All patients had a CT scan before endovascular man-
agement. The scan showed a pseudoaneurysm with active
bleeding in four patients and without active bleeding in six.
A mean of 24 days (range, 7-60 days) passed between the
initial surgery or trauma and the diagnosis of pseudoaneu-
rysm. The pseudoaneurysm site involved the common he-
patic artery or branches in 8 patients, the splenic artery in 1,
and the superior mesenteric artery in 1 (Fig 2).
The procedure was performed under emergency con-
ditions in eight patients (80%) because of hemodynamic
instability, and at 24 hours after the CT scan diagnosis for
the two other patients.
A femoral access was used in 8 patients, a brachial access
in 1, and both types of access in 1. Only one Viabahn (W. L.
Gore & Associates, Flagstaff, Ariz) stent graft, measuring
6 25 mm or 6 50 mm was used per patient to treat the
lesion, except for two patients. A splenic artery pseudoan-
eurysm in one patient required two 6-  50-mm stent
grafts for hemostasis to be achieved and the second, with
relatively large hepatic artery, was treated with a 7- 
25-mm Viabahn. Given the risk of artery rupture, oversiz-
ing and inflation of the stent graft were avoided. In two
cases of endoleak in the completion angiogram, a 6- 
20-mm balloon was carefully inflated to allow a good
sealing of the stent graft. The mean duration for the pro-
cedure was 50 minutes (range, 40-80 minutes). All patients
had preoperative or perioperative transfusion, with a mean
number of 4 units of packed red cells (range, 2-10 units).
In intention-to-treat analysis, technical and clinical suc-
cess was achieved in eight patients (80%). Failure in the
other two patients was attributed to the inability to cathe-
terize the hepatic artery, which required relaparotomy. tThe successfully treated patients rapidly regained he-
odynamic stability with complete exclusion of the pseu-
oaneurysm on the completion angiogram. A nonsignifi-
ant stenosis was noted in one patient related to vascular
pasm.
The postoperative mortality rate was 20%. The two
atients treated surgically after failure of the stent graft
eployment died of multiple organ failure on days 1 and 4.
The intensive care unit length of stay for the survivors
as a mean of 10 days (range, 0-45 days), and hospital
ength of stay after the endovascular procedure was a mean
f 34 days (range 9-80 days). No complications occurred
uring the perioperative period related to the endovascular
reatment. Of two patients with sepsis and a significant
bdominal collection, percutaneous drainage of pancreatic
eakage was required in one and biliary leakage in the
econd. All patients with sepsis received 3 weeks of intrave-
ous antibiotic therapy covering pathogens isolated from
ultures and were then switched to oral therapy for 3 to 6
onths, generally with fluoroquinolones plus clindamycin
r cotrimoxazole plus clindamycin. The choice of the anti-
iotic and the duration of administration were at the clini-
ian’s discretion.
Follow-up data were available for all patients, with a
ean follow-up of 37 months (range, 10-63 months).
ostoperative imaging consisted of a CT scan in seven
atients and Doppler ultrasound imaging in one patient.
ll the stent grafts remained patent, with no evidence of
estenosis. No patients had any rebleeding or recurrence of
he pseudoaneurysm. In addition, none of these patients
howed any stent graft infection or other septic complica-
ions (Fig 2, C). Two patients died during the follow-up
eriod secondary to neoplasm (Table).
ISCUSSION
Visceral artery pseudoaneurysm is an uncommon but
ell-documented entity1,2 that differs from a true aneu-
ysm. The severity of this pathology is related to misdiag-
osis and a risk of rupture that is much higher than with
rue aneurysms in the same location.20
The clinical presentations of true aneurysms and pseu-
oaneurysms are different. The latter are more likely to be
ymptomatic and frequently require urgent interven-
ion.1,20 In our series, as in the literature,20 80% of our
atients were treated under emergency circumstances.
Different mechanisms are incriminated in the occur-
ence of iatrogenic pseudoaneurysms, including (1) direct
ascular injury during dissection or removal of adjacent
ymphatic nodes and connective tissue in cases of malig-
ancy, (2) erosion of the arterial vessels resulting from a
ancreatic, biliary, or enteric fistula, and (3) local sepsis.21
hese physiopathologic mechanisms are generally inter-
elated.
Pseudoaneurysm formation after trauma has been doc-
mented as a result of rapid deceleration with intimal
amage and weakening of the arterial wall.22 The splenic
nd superior mesenteric arteries are particularly vulnerable
o these injuries because they are fixed at their origin and
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ment of blunt splenic trauma contributes to the increase in
incidence of post-traumatic aneurysm in this location.23
Management of these pseudoaneurysms must take into
account three elements—hemodynamic status, potential
septic complications, and the diffuse intra-abdominal in-
flammatory process—that make the surgical approach tech-
nically difficult and increase the risk of operative repair.
Table. Patient data, treatment, and outcomes
Patient Age
Initial
pathology Surgery
Onset
(day)
Signs and physi
examination
1 71 Ampulloma PD 29 Right upper
abdominal
pain, melena
2 52 Pancreatic
carcinoma
PD 16 Sentinel bleedi
1 day earlier
external
bleeding
through
abdominal
drains, uppe
GI bleeding
3 65 Bile duct
carcinoma
PD 22 Upper GI
bleeding wit
shock
4 47 Pancreatic
carcinoma
PD 27 Anemia, diffus
abdominal
pain, pulsati
mass in the
right upper
abdomen
5 76 Pancreatic
carcinoma
PD 18 Upper GI
bleeding,
melena with
shock
6 71 Gastric
carcinoma
Gastrectomy 21 Upper GI
bleeding,
melena
7 75 Bile duct
carcinoma
PD 7 Sentinel bleedi
2 days earlie
melena,
external
bleeding
through
abdominal
drains, shoc
8 56 Mucinous
neoplasm
PD 24 Fever, shock,
melena
9 53 Endocrine
tumor
PD 20 Sentinel bleedi
7 days earlie
upper GI
bleeding,
shock
10 23 Traffic
trauma
60 Abdominal pai
melena, larg
pulsatile ma
CHA, Common hepatic artery; GI, gastrointestinal; MOF, multiple organ
superior mesenteric artery.Mortality rates after conventional treatment have been iocumented as 5% for elective treatment and from 10% to
5% for ruptures.3-6
Endovascular techniques with arterial embolization or
tent grafts have been proposed as an alternative to surgical
epair and offer real advantages in terms of survival.20
The main concerns with embolization techniques are
he recurrence of bleeding, which was pointed out by
arby et al,24 and end-organ ischemia with subsequent
Site Shock Sepsis Infectious agent Outcome
HA Yes No 63 months, no
SG-related
complications
HA Yes Yes Streptococcus
spp, Proteus
mirabilis
Died 4 days
after
relaparotomy
of MOF
HA Yes Yes Enterococcus
faecium,
Escherichia
coli
56 months, died
secondary to
neoplasm
HA No Yes Fusobacterium
necrophorum
10 months, died
secondary to
neoplasm
HA Yes No Died of MOF 1
day after
relaparotomy
plenic
artery
No No 41 months, no
SG-related
complications
HA Yes Yes with
pancreatic
fistula
Candida
glabrata,
Pseudomonas
aeruginosa,
Escherichia
coli
36 months, no
SG-related
complications
HA Yes Yes Streptococcus
spp,
Klebsiella
pneumoniae,
Escherichia
coli
28 months, no
SG-related
complications
HA Yes Yes with
pancreatic
fistula
Streptococcus
spp,
Pseudomonas
aeruginosa
48 months, no
SG-related
complications
MA Yes No 15 months, no
SG-related
complications
; PD, pancreaticoduodenectomy; SA, splenic artery; SG, stent graft; SMA,cal
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Volume 53, Number 6 Boufi et al 1629for high mortality and morbidity rates, notably if the com-
mon hepatic artery becomes occluded.25-29 Descriptions of
Fig 2. A, An axial view of abdominal computed tomography scan
shows a 5-  6-cm pseudoaneurysm of the superior mesenteric
artery in a 23-year-old man who sustained a blunt abdominal
trauma 8 weeks earlier. B, A selective angiogram of the superior
mesenteric artery shows contrast extravasation. C, A multiplanar
computed tomography reconstruction at 12 months documents
patency of the stent graft, shrinkage of the pseudoaneurysm, and
no evidence of infection.embolization materials migrating into the visceral arteries, morta, or gastrointestinal tract, which remains a potential
omplication for this procedure,30 have also been reported.
Stent graft placement has several advantages compared
ith other techniques:
First, it makes possible effective hemostasis and throm-
osis of the pseudoaneurysm without risk of rebleeding. All
he cases reported in the literature were technically success-
ul.17 In our series, except for two failures, the successfully
eployed stent grafts allowed complete exclusion of the
seudoaneurysm.
Second, it is associated with lower morbidity17 com-
ared with embolization or surgery in appropriate candi-
ates, mainly thanks to preserved organ perfusion. Ana-
omic suitability is crucial to avoid disadvantages related to
ranch vessel exclusion or kinking of the stent graft. Favor-
ble anatomy for stent graft deployment includes proximal
rtery lesions, adequate proximal and distal neck, a 5- to
0-mm length of artery before and after the lesion, without
rterial division and adequate caliber, and a vessel path
llowing for safe catheter navigation.
No deaths or complications have been reported in the
iterature, except a case of stent graft occlusion caused by
he kinking of the stent graft that was successfully treated by
he deployment of aWallstent (Boston Scientific) across the
tent graft.31
In our series, we used only Viabahn-type expandable
tent grafts because of the flexibility and accuracy of the
elivery system. The general trend is to use balloon-
xpandable stent grafts with the over-the-wire tech-
ique. Stoupis et al32 proposed the use of monorail
elf-expandable stent grafts in case of tortuous and small
rteries.
Finally, sepsis is not an absolute contraindication for
tent graft placement. Close long-term follow-up is never-
heless mandatory. In a literature review by Miller et al,17
o case of stent graft infection was reported in the out-
ome.
Scepticism exists about the placement of stent grafts
n the context of infection or inflammation. The satisfac-
ory results reported with stent graft use in the treatment
f infected pseudoaneurysms, mycotic aneurysms, or
ortoesophageal fistula,33-36 however, is an argument
hat can be used to moderate these concerns. In the
resent series, we did not find any clinical or imaging
igns of stent graft infection after a mean follow-up of 37
onths. We believe that control of infection by admin-
stration of antibiotics and the maintenance of this ther-
py for a long period, along with the surgical or the
ercutaneous drainage of collections, is crucial to pre-
ent the risk of graft contamination. In our practice,
ntravenous antibiotics were systematically administered
erioperatively and prolonged with oral therapy for 3 to
months in patients with preoperative sepsis.
All reports of stent graft exclusion of visceral artery
seudoaneurysms concerned case reports with short-
erm follow-up,13-16 except for two case reports, by
owan et al37 and Qu et al,38 with clinical success at 60
onths after implantation without any imaging studies
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study is the first series with available midterm assessment
of results with clinical and imaging evaluation. Patients
in our series had regular examinations and CT scans or
Doppler ultrasound imaging during the follow-up, and
no restenosis or occlusion of the stent grafts was docu-
mented at midterm.
The present study has limitations related to the retrospec-
tive design and the small number of patients. Our results
should thus be regarded with caution. However, we believe
that this technique can be proposed for all patients with
visceral pseudoaneurysms and suitable anatomy, and not only
for patients with failed embolization or those with a high risk
of organ infarction, as recommended by some authors.16
CONCLUSIONS
The different case reports published in the literature
have shown that the use of stent grafts in the treatment of
bleeding visceral artery pseudoaneurysms is feasible, effec-
tive, and safe. Our series consolidates these facts by supply-
ingmidterm results showing good patency, with no signs of
stent graft infection.
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